Author

Steffen Lemke

Observed name: Lemke, Steffen

Institutions: Universitätsklinikum Tübingen, Quantitative Biology Center, University of Tübingen

Observed institutions: Universitätsklinikum Tübingen, Quantitative Biology Center, University of Tübingen

ORCID: 0009-0009-8121-082X

Observed ORCID: 0009-0009-8121-082X

OpenAlex ID: A5064138488

Chromosome 8p engineering reveals increased metastatic potential targetable by patient-specific synthetic lethality in liver cancer

2023 · Thorben Huth, Emely C. Dreher, et al. · Science Advances · 26

PCI-DB: a novel primary tissue immunopeptidome database to guide next-generation peptide-based immunotherapy development

2025 · Steffen Lemke, Marissa L Dubbelaar, et al. · Journal for ImmunoTherapy of Cancer · 12

MHCquant2 refines immunopeptidomics tumor antigen discovery

2025 · Jonas Scheid, Steffen Lemke, et al. · Genome biology · 5

Adenosine Receptor 3 in Liver Cancer: Expression Variability, Epigenetic Modulation, and Enhanced Histone Deacetylase Inhibitor Effects

2024 · Louise Kaldjob-Heinrich, Sandro Nuciforo, et al. · Gastro Hep Advances · 5

Stroma-driven intertumoral and intratumoral heterogeneity of PD-L1 expression in cholangiocarcinoma: Implications for biomarker development and prognostic evaluation

2026 · Anna Saborowski, Peter Simon, et al. · Hepatology · 2

MHCquant2 refines immunopeptidomics tumor antigen discovery

2024 · Jonas Scheid, Steffen Lemke, et al. · Research Square · 2

PCI-DB: A novel primary tissue immunopeptidome database to guide next-generation peptide-based immunotherapy development

2024 · Steffen Lemke, Marissa L. Dubbelaar, et al. · Research Square · 1

Deep learning enables direct HLA typing from immunopeptidomics data

2026 · Matteo Pilz, Jonas Scheid, et al. · bioRxiv (Cold Spring Harbor Laboratory)

1239 Uncovering the dark side of the immunopeptidome

2025 · Marcel Wacker, Steffen Lemke, et al. · Regular and Young Investigator Award Abstracts

Works count: 16

Citation count: 60

H-index: 4

I10-index: 2